JPS6130645B2 - - Google Patents

Info

Publication number
JPS6130645B2
JPS6130645B2 JP9529980A JP9529980A JPS6130645B2 JP S6130645 B2 JPS6130645 B2 JP S6130645B2 JP 9529980 A JP9529980 A JP 9529980A JP 9529980 A JP9529980 A JP 9529980A JP S6130645 B2 JPS6130645 B2 JP S6130645B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
groups
compound
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9529980A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5721321A (en
Inventor
Setsuo Fujii
Toshihiro Hamakawa
Kazuo Ogawa
Yoshuki Muranaka
Sadao Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP9529980A priority Critical patent/JPS5721321A/ja
Priority to US06/225,979 priority patent/US4411911A/en
Priority to GB8101888A priority patent/GB2068371B/en
Priority to AU66677/81A priority patent/AU527933B2/en
Priority to CA000369549A priority patent/CA1167046A/en
Priority to CH599/81A priority patent/CH655098A5/de
Priority to FR8101712A priority patent/FR2475041A1/fr
Priority to KR1019810000273A priority patent/KR840000419B1/ko
Priority to DE19813103144 priority patent/DE3103144A1/de
Priority to ES499527A priority patent/ES8201964A1/es
Priority to NLAANVRAGE8100494,A priority patent/NL185343C/xx
Publication of JPS5721321A publication Critical patent/JPS5721321A/ja
Priority to US06/492,873 priority patent/US4489091A/en
Priority to KR1019830005681A priority patent/KR840001439B1/ko
Priority to KR1019830005680A priority patent/KR840001438B1/ko
Publication of JPS6130645B2 publication Critical patent/JPS6130645B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP9529980A 1980-01-31 1980-07-11 Antihyperlipemic agent Granted JPS5721321A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
JP9529980A JPS5721321A (en) 1980-07-11 1980-07-11 Antihyperlipemic agent
US06/225,979 US4411911A (en) 1980-01-31 1981-01-19 Method of treating hyperlipidemia and inflammation with sulfonate derivatives
GB8101888A GB2068371B (en) 1980-01-31 1981-01-22 Sulphonate derivatives
AU66677/81A AU527933B2 (en) 1980-01-31 1981-01-28 Sulphonate derivatives
CA000369549A CA1167046A (en) 1980-01-31 1981-01-28 Sulfonate derivatives
KR1019810000273A KR840000419B1 (ko) 1980-07-11 1981-01-29 술포네이트 유도체의 제조방법
FR8101712A FR2475041A1 (fr) 1980-01-31 1981-01-29 Esters sulfoniques de ceto-alcools, leur preparation et medicament contenant ces substances
CH599/81A CH655098A5 (de) 1980-01-31 1981-01-29 Sulfonatderivate, verfahren zu deren herstellung sowie pharmazeutische mittel, dieselben enthaltend.
DE19813103144 DE3103144A1 (de) 1980-01-31 1981-01-30 Neue sulfonate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
ES499527A ES8201964A1 (es) 1980-01-31 1981-01-30 Procedimiento de preparar derivados sulfonato
NLAANVRAGE8100494,A NL185343C (nl) 1980-01-31 1981-02-02 Gevormde farmaceutische preparaten met antilipemische ontstekingswerende en immuniteitregelende werking en daarvoor geschikte sulfonaatverbindingen en een bereidingswijze.
US06/492,873 US4489091A (en) 1980-01-31 1983-05-09 Antilipemic and anti-inflammatory compositions containing sulfonate derivatives
KR1019830005681A KR840001439B1 (ko) 1980-07-11 1983-11-30 술포네이트 유도체의 제조방법
KR1019830005680A KR840001438B1 (ko) 1980-07-11 1983-11-30 술포네이트 유도체의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9529980A JPS5721321A (en) 1980-07-11 1980-07-11 Antihyperlipemic agent

Publications (2)

Publication Number Publication Date
JPS5721321A JPS5721321A (en) 1982-02-04
JPS6130645B2 true JPS6130645B2 (enrdf_load_html_response) 1986-07-15

Family

ID=14133887

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9529980A Granted JPS5721321A (en) 1980-01-31 1980-07-11 Antihyperlipemic agent

Country Status (1)

Country Link
JP (1) JPS5721321A (enrdf_load_html_response)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH084081B2 (ja) * 1986-04-28 1996-01-17 ソニー株式会社 シリコンウエフアの洗浄方法
JPS631403U (enrdf_load_html_response) * 1986-06-23 1988-01-07
JPH01112705U (enrdf_load_html_response) * 1988-01-25 1989-07-28

Also Published As

Publication number Publication date
JPS5721321A (en) 1982-02-04

Similar Documents

Publication Publication Date Title
KR880002298B1 (ko) 술포네이트 유도체의 제조법
US5366997A (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
EP0017195B1 (en) Derivatives of 2,5-disubstituted-cyclohexane-1,3-diones, process for preparation thereof and pharmaceutical composition containing them
JPS61246184A (ja) ジアンヒドロヘキシツト誘導体、その製造方法およびその医薬としての用途
DE68916174T2 (de) Mevalonolactone vom Thienopyridin-Typ.
KR930001835B1 (ko) 신규 히단토인(Hydantoin) 유도체의 제조방법
CN103524318B (zh) 一类含烯丙基的单羰基姜黄素类似物在制备抗炎药物中的应用
EP0154887B1 (en) New 2,5-diaryl tetrahydrothiophenes and analogs thereof as paf-antagonists
CA1176273A (en) Substituted oxocarboxylic acids, processes for their preparation, their use and medicaments containing them
JPS609716B2 (ja) １，２―ベンズインチアゾリン―３―オン類、それらの製造法および医薬としての使用
EP0180190B1 (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
JPH08505362A (ja) Ｐａｆレセプター拮抗剤及び５−リポキシゲナーゼ阻害剤としての、２，４−ジアリール−１，３−ジチオラン、２，４−ジアリール−１，３−ジオキソラン、２，４−ジアリール−１，３−オキサチオラン、及び２，５−ジアリール−１，３−オキサチオラン
WO1994002457A1 (en) Prostaglandin derivative
EP0074411B1 (en) Ascorbic acid derivatives
JPS6130645B2 (enrdf_load_html_response)
EP0101898A1 (de) Anellierte 4H-1,4-Benzothiazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JPH0615533B2 (ja) ピラジン誘導体およびこれを含有する血小板凝集抑制剤
US4628062A (en) 1,4-naphthoquinone derivatives having anti-inflammatory action
EP0026000B1 (en) Spiro compounds, process for their preparation and pharmaceutical compositions containing them
JP7052043B2 (ja) 不飽和脂肪族オレフィン性結合を含有するチエノピリジン誘導体、その調製方法および使用
WO1999002527A1 (fr) Derives de naphthyridine
US5578596A (en) 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivatives, and production method and use thereof
EP0100527B1 (de) 4H-1,4-Benzothiazine zur Verwendung als Arzneimittel
JP3049284B2 (ja) ヒダントイン誘導体並びにそれを有効成分とする糖尿病合併症及び循環器系疾患の予防及び治療剤
CZ279793A3 (en) Orally active antiviral compounds